Replication of equine infectious anemia virus in engineered mouse NIH 3T3 cells

Journal of Virology

Volumn 83, Issue 4, 2009, Pages 2034-2037

  Zhang, Baoshan ^a   Montelaro, Ronald C ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; CYCLINE T1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BUDDING; CELL INTERACTION; CELL LINE; CELL STRAIN 3T3; CONTROLLED STUDY; EQUINE INFECTIOUS ANEMIA VIRUS; HORSE DISEASE; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRION; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS TYPING;

ANIMALS; CYCLINS; HIV-1; INFECTIOUS ANEMIA VIRUS, EQUINE; MICE; NIH 3T3 CELLS; RECEPTORS, VIRUS;

EQUIDAE; EQUINE INFECTIOUS ANEMIA VIRUS; EQUINE LENTIVIRUSES; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; MURINAE;

EID: 59649117843     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01883-08     Document Type: Article

References (19)

1. Baumann, J. G., D. Unutmaz, M. D. Miller, S. K. Breun, S. M. Grill, J. Mirro, D. R. Littman, A. Rein, and V. N. KewalRamani. 2004. Murine T cells potently restrict human immunodeficiency virus infection. J. Virol. 78:12537-12547.
2. Bieniasz, P. D., and B. R. Cullen. 2000. Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells. J. Virol. 74:9868-9877.
3. Bieniasz, P. D., T. A. Grdina, H. P. Bogerd, and B. R. Cullen. 1999. Highly divergent lentiviral Tat proteins activate viral gene expression by a common mechanism. Mol. Cell. Biol. 19:4592-4599.
4. Browning, J., J. W. Horner, M. Pettoello-Mantovani, C. Raker, S. Yurasov, R. A. DePinho, and H. Goldstein. 1997. Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection. Proc. Natl. Acad. Sci. USA 94:14637-14641.
5. Cook, R. F., S. J. Cook, F. L. Li, R. C. Montelaro, and C. J. Issel. 2002. Development of a multiplex real-time reverse transcriptase-polymerase chain reaction for equine infectious anemia virus (EIAV). J. Virol. Methods 105:171-179.
6. Garber, M. E., P. Wei, V. N. KewalRamani, T. P. Mayall, C. H. Herrmann, A. P. Rice, D. R. Littman, and K. A. Jones. 1998. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev. 12:3512-3527.
7. Hammond, S. A., S. J. Cook, D. L. Lichtenstein, C. J. Issel, and R. C. Montelaro. 1997. Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process. J. Virol. 71:3840-3852.
8. Hatziioannou, T., S. Cowan, and P. D. Bieniasz. 2004. Capsid-dependent and -independent postentry restriction of primate lentivirus tropism in rodent cells. J. Virol. 78:1006-1011.
9. Hubner, W., and B. K. Chen. 2006. Inhibition of viral assembly in murine cells by HIV-1 matrix. Virology 352:27-38.
10. Jin, J., T. Sturgeon, C. Chen, S. C. Watkins, O. A. Weisz, and R. C. Montelaro. 2007. Distinct intracellular trafficking of equine infectious anemia virus and human immunodeficiency virus type 1 Gag during viral assembly and budding revealed by bimolecular fluorescence complementation assays. J. Virol. 81:11226-11235.
11. Jin, S., B. Zhang, O. A. Weisz, and R. C. Montelaro. 2005. Receptor-mediated entry by equine infectious anemia virus utilizes a pH-dependent endocytic pathway. J. Virol. 79:14489-14497.
12. Lichtenstein, D. L., K. E. Rushlow, R. F. Cook, M. L. Raabe, C. J. Swardson, G. J. Kociba, C. J. Issel, and R. C. Montelaro. 1995. Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity. J. Virol. 69:2881-2888.
13. Mariani, R., G. Rutter, M. E. Harris, T. J. Hope, H. G. Krausslich, and N. R. Landau. 2000. A block to human immunodeficiency virus type 1 assembly in murine cells. J. Virol. 74:3859-3870.
14. Montelaro, R. C., J. M. Ball, and K. E. Rushlow. 1993. Equine retroviruses, p. 257-360. In J. Levy (ed.), The Retroviridae. Plenum Press, New York, NY.
15. Reed, M., R. Mariani, L. Sheppard, K. Pekrun, N. R. Landau, and N. W. Soong. 2002. Chimeric human immunodeficiency virus type 1 containing murine leukemia virus matrix assembles in murine cells. J. Virol. 76:436-443.
16. Taube, R., K. Fujinaga, D. Irwin, J. Wimmer, M. Geyer, and B. M. Peterlin. 2000. Interactions between equine cyclin T1, Tat, and TAR are disrupted by a leucine-to-valine substitution found in human cyclin T1. J. Virol. 74:892-898.
17. van Maanen, M., and R. E. Sutton. 2003. Rodent models for HIV-1 infection and disease. Curr. HIV Res. 1:121-130.
18. Wei, P., M. E. Garber, S. M. Fang, W. H. Fischer, and K. A. Jones. 1998. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92:451-462.
19. Zhang, B., S. Jin, J. Jin, F. Li, and R. C. Montelaro. 2005. A tumor necrosis factor receptor family protein serves as a cellular receptor for the macrophage-tropic equine lentivirus. Proc. Natl. Acad. Sci. USA 102:9918-9923.